<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04272216</url>
  </required_header>
  <id_info>
    <org_study_id>TIS2019-02</org_study_id>
    <nct_id>NCT04272216</nct_id>
  </id_info>
  <brief_title>An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres</brief_title>
  <acronym>RAVI Registry</acronym>
  <official_title>The RAVI Registry: A Prospective, Multi-Center, Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Terumo Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Terumo Medical Corporation</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry study is designed to collect data on the procedural success and complication
      rates in real-world patients undergoing HydroPearl embolization procedures via radial access.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 6, 2020</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>During procedure</time_frame>
    <description>defined as completing the planned procedure without femoral access bailout</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Technical Success</measure>
    <time_frame>End of procedure</time_frame>
    <description>delivery of HydroPearl to the target vessel and slowing the blood flow with microsphere embolization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Freedom from major adverse events and radial access complications</measure>
    <time_frame>within 30 days post-procedure</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Uterine Fibroid</condition>
  <condition>Arteriovenous Malformations</condition>
  <condition>Hypervascular Tumors</condition>
  <arm_group>
    <arm_group_label>Treatment with HydroPearl via radial access</arm_group_label>
    <description>all patients will be in the same group/cohort in this open-label, single-arm, observational registry.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treatment with HydroPearl via radial access</intervention_name>
    <description>This is an observational study collecting data on patients who are already being treated with HydroPearl on-label per standard of care.</description>
    <arm_group_label>Treatment with HydroPearl via radial access</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This is a prospective, multi-center, registry study to assess the procedural success,
        technical success, and complication rate of radial access procedures using HydroPearl
        microspheres.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is â‰¥ 18 years old

          2. Subject is scheduled for a procedure for treatment with HydroPearl microspheres using
             radial access.

          3. Subject is willing and able to complete follow-up requirements

          4. Subject is willing and able to sign a written Informed Consent form prior to
             participating in the registry.

        Exclusion Criteria:

          1. Unable to have a procedure with radial access for any reason.

          2. Participating in another clinical study which, in the opinion of the investigator,
             could impact the results of this registry.

          3. Pregnant or planning to become pregnant during the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcelo Guimaraes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carmela Cusumano</last_name>
    <phone>908-307-3755</phone>
    <email>carmela.cusumano@terumomedical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>SLU Department of Radiology</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Hardy, MPH, RN</last_name>
      <phone>314-268-5785</phone>
      <email>Anna.hardy@health.clu.edu</email>
    </contact>
    <investigator>
      <last_name>Kirubahara Vaheesan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UNC</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Desma Jones</last_name>
      <phone>919-843-9463</phone>
      <email>Desma_Jones@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Jessica Stewart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Norton</last_name>
      <phone>843-792-8874</phone>
      <email>nortons@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Marcelo Guimaraes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>February 13, 2020</study_first_submitted>
  <study_first_submitted_qc>February 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2020</study_first_posted>
  <last_update_submitted>June 22, 2020</last_update_submitted>
  <last_update_submitted_qc>June 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Arteriovenous Malformations</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

